Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 1-13 , January 2009

Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review

  • Birgitte V. Offersen

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    • Corresponding Author InformationCorresponding author. Department of Oncology, Aarhus University Hospital, Nørrebrogade 44, bld. 5, DK-8000 Aarhus C, Denmark.
    • ,
  • Marie Overgaard

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    • ,
  • Niels Kroman

      Affiliations

    • Department of Breast Surgery, Rigshospitalet, Denmark
    • ,
  • Jens Overgaard

      Affiliations

    • Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark

Received 5 May 2008 ,Revised 8 August 2008 ,Accepted 13 August 2008.

References 

  1. Clarke M. Meta-analyses of adjuvant therapies for women with early breast cancer: The Early Breast Cancer Trialists’ Collaborative Group overview. Ann Oncol. 2006;17
  2. Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  3. EBCTCG. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialist Collaborative Group. Lancet 2000;355:1757–1770.
  4. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van Den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–1387
  5. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van Den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25:3259–3265
  6. Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer. 1996;77:1094–1100
  7. Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001;93:1344–1346
  8. Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148–1153
  9. Virnig B, Habermann E, Al-Refaie M, Jensen E, and Tuttle T. Increased use of breast-conserving surgery: preferred treatment or failure to provide adequate local therapy? Breast Cancer Research and Treatment 106;2007. (abstract).
  10. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1–2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–990
  11. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996;74:820–824
  12. Faverly DRG, Hendriks JHCL, Holland R. Breast carcinomas of limited extent: frequency, radiologic–pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647–659
  13. Frazier TG, Wong RWY, Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg. 1989;124:37–38
  14. Rosen PP, Fracchia AA, Urban JA. ‘Residual’ mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35:739–747
  15. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997–1003
  16. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456–1461
  17. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabār L, Nordgren H, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326–2333
  18. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  19. Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351
  20. Malmstrom P, Holmberg L, Anderson H, Mattsson J, Svensson PE, Tennvall-Nittby L, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer. 2003;39:1690–1697
  21. Winzer KJ, Sauer R, Sauerbrei W, Schneller E, Jaeger W, Braun M, et al. Radiation therapy after breast-conserving surgery: first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer. 2004;40:998–1005
  22. Holli K, Saaristo R, Isola J, Joensuu H, Hakama M. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer. 2001;84:164–169
  23. Touboul E, Buffat L, Mi Y, Lefranc JP, Uzan S, Lhuillier P, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25–38
  24. Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N. Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2005;61:1328–1336
  25. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038–1045
  26. Cook LS, White E, Schwartz SM, McKnight B, Daling JR, Weiss NS. A population-based study of contralateral breast cancer following a first primary cancer (Washington, United States). Cancer Causes Control. 1996;7:299–301
  27. Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK. Second primary in the contralateral breast after treatment of breast cancer. Radiother Oncol. 2008;86:171–176
  28. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of the contralateral breast cancer. Cancer Epidemiol Biomark Prev. 1999;8:855–861
  29. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 1996;88:1659–1664
  30. Mannino M, Yarnold J. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld. Radiother Oncol 2008; doi:10.1016/j.radonc.2008.05.002.
  31. Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681–689
  32. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–293
  33. Baglan KL, Sharpe MB, Jaffray D, Frazier RC, Fayad J, Kestin LL, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302–311
  34. Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys. 2005;63:1531–1537
  35. Orecchia R, Veronesi U. Intraoperative electrons. Semin Radiat Oncol. 2005;15:76–83
  36. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 2001;37:2178–2183
  37. Vaidya JS, Tobias JS, Baum M, Wenz F, Kraus-Tiefenbacher U, D’Souza D, et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol. 2005;15:84–91
  38. Bovi J, Qi XS, White J, Li XA. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. Radiother Oncol. 2007;84:226–232
  39. Weed DW, Edmundson GK, Vicini FA, Chen PY, Martinez AA. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy. 2005;4:121–129
  40. Patel RR, Becker SJ, Das RK, Mackie TR. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;68:935–942
  41. Major T, Niehoff P, Kovacs G, Fodor J, Polgar C. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol. 2006;79:321–328
  42. Petersen RP, Truong PT, Kader HA, Berthelet E, Lee JC, Hilts ML, et al. Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys. 2007;69:41–48
  43. Weed DW, Yan D, Martinez AA, Vicini FA, Wilkinson TJ, Wong J. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2004;60:484–492
  44. Landis DM, Luo W, Song J, Bellon JR, Punglia RS, Wong JS, et al. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007;67:1299–1308
  45. Wong EK, Truong PT, Kader HA, Nichol AM, Salter L, Petersen R, et al. Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. Int J Radiat Oncol Biol Phys. 2006;66:372–376
  46. White EA, Cho J, Vallis KA, Sharpe MB, Lee G, Blackburn H, et al. Cone beam computed tomography guidance for setup of patients receiving accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2007;68:547–554
  47. Fatunase T, Zhiheng W, Yoo S, Hubbs JL, Prosnitz RG, Yin F, et al. Assessment of the residual error in soft tissue setup in patients undergoing partial breast irradiation: results of a prospective study using cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2008;70:1025–1034
  48. Overgaard M, Bentzen SM, Christensen JJ, Madsen EH. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol. 1987;9:1–12
  49. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7:467–471
  50. Guerrero M, Li X. Analysis of a large number of clinical studies of breast cancer radiotherapy: estimation of radiobiological parameters. Phys Biol Med. 2003;48:3307–3326
  51. Joiner MC, van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG, editor. Basic clinical radiobiology, 2nd ed. 2002.
  52. Veronesi U, Gatti G, Luini A, Intra M, Orecchia R, Borgen P, et al. Intraoperative radiation therapy for breast cancer: technical notes. Breast J. 2003;9:106–112
  53. Suh WW, Pierce LJ, Vicini FA, Hayman JA. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005;62:790–796
  54. Bartelink H. Intraoperative radiotherapy for breast cancer: tail wagging the dog?. Lancet Oncol. 2004;5:207–208
  55. Baglan KL, Martinez AA, Frazier RC, Kini VR, Kestin LL, Chen PY, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2001;50:1003–1011
  56. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205–1211
  57. Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, et al. Surgical considerations in the treatment of early stage breast cancer with accelerated partial breast irradiation (APBI) in breast conserving therapy via interstitial brachytherapy. Am J Surg. 2004;188:355–364
  58. Chen PY, Vicini FA, Benitez P, Kestin LL, Wallace M, Mitchell C, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991–999
  59. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins J, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1, 2) breast cancer. Am J Surg. 2000;180:299–304
  60. Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95–17. Int J Radiat Oncol Biol Phys. 2006;65:45–51
  61. Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57:1239–1246
  62. Wazer DE, Lowther D, Boyle T, Ulin K, Neuschatz ARR, DiPetrillo T. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2001;50:107–111
  63. Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:889–897
  64. Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–495
  65. Lawenda BD, Taghian AG, Kachnic LA, Hamdi H, Smith BL, Gadd MA, et al. Dose–volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56:671–680
  66. Kaufman SA, DiPetrillo TA, Price LL, Midle JB, Wazer DE. Long-term outcome and toxicity in a phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy. 2007;6:286–292
  67. Krishnan L, Jewell WR, Tawfik OW, Krishnan EC. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91–96
  68. Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HMO, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32:608–611
  69. Fentiman IS, Poole C, Tong D, Winter PJ, Mayles HMO, Turner P, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 1991;27:447–450
  70. Fentiman IS, Deshmane V, Tong D, Winter J, Mayles H, Chaudary MA. Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol. 2004;71:281–285
  71. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I–II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–128
  72. Polgar C, Major T, Fodor J, Nemeth G, Orosz Z, Sulyok Z, et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  73. Polgar C, Fodor J, Major T, Nemeth G, Lovey K, Orosz Z, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  74. Lovey K, Fodor J, Major T, Szabo E, Orosz Z, Sulyok Z, et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy-4-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:724–731
  75. Ott OJ, Hildebrandt G, Pötter R, Hammer J, Lotter M, Resch A, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German–Austrian multi-centre trial. Radiother Oncol. 2007;82:281–286
  76. Ott OJ, Lotter M, Sauer R, Strnad V. Accelerated partial-breast irradiation with interstitial implants: the clinical relevance of the calculation of skin doses. Strahlenther Onkol. 2007;183:426–431
  77. Ott OJ, Pötter R, Hammer J, Hildebrandt G, Lotter M, Resch A, et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy: preliminary results of the German–Austrian multicenter trial. Strahlenther Onkol. 2004;180:642–649
  78. Ott OJ, Schulz-Wendtland R, Uter W, Pfahlberg A, Beckmann MW, Sauer R, et al. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. Strahlenther Onkol. 2005;181:638–644
  79. Harris JR, Levine M, Svensson G, Hellman S. Analysis of the cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979;5:257–261
  80. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  81. LENT SOMA tables. Radiother Oncol 1995;35:17–60.
  82. Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32–40
  83. Zannis V, Beitsch P, Vicini F, Quiet C, Keleher A, Garcia D, et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg. 2005;190:530–538
  84. Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11:739–746
  85. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American society of breast surgeons MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112:758–766
  86. Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HG, et al. First analysis of patient demographics, technical reproducibility, cosmesis and early toxicity: results of the American society of surgeons MammoSite breast brachytherapy registry trial. Cancer. 2005;104:1138–1148
  87. Sadeghi A, Prestidge B, Lee J, Rosenthal A. Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite applicator. Brachytherapy. 2006;5:230–234
  88. Difronzo LA, Tsai PI, Hwang JM, Lee JJ, Ryoo MC, Rahimian J, et al. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience. Arch Surg. 2005;140:787–794
  89. Tsai PI, Ryan M, Meek K, Ryoo MC, Tome M, Takasugi J, et al. Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up. Am Surg. 2006;72:929–934
  90. Chen S, Dickler A, Kirk M, Shah A, Jokich P, Solmos G, et al. Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys. 2007;69:25–31
  91. Dickler A, Kirk MC, Choo J, Hsi WC, Chu J, Dowlatshahi K, et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J. 2005;11:306–310
  92. Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE. Acute complications of MammoSite brachytherapy: a single institution’s initial clinical experience. Int J Radiat Oncol Biol Phys. 2005;61:169–174
  93. Shah NM, Tenenholz T, Arthur D, DiPetrillo T, Bornstein B, Cardarelli G, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer. 2004;101:727–734
  94. Evans SB, Kaufman SA, Price LL, Cardarelli G, DiPetrillo TA, Wazer DE. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing actors. Int J Radiat Oncol Biol Phys. 2006;65:333–339
  95. Niehoff P, Polgar C, Ostertag H, Major T, Sulyok Z, Kimmig B, et al. Clinical experience with the MammoSite® radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79:316–320
  96. Niehoff P, Ballardini B, Polgar C, Major T, Hammer J, Richetti A, et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast. 2006;15:319–325
  97. Vicini FA, Chen P, Wallace M, Mitchell C, Hasan Y, Grills I, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69:1124–1130
  98. Formenti SC, Rosenstein B, Skinner KA, Jozsef G. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients – pilot feasibility study. Radiat Oncol. 2002;222:171–178
  99. Formenti SC, Truong MT, Goldberg JD, Mukhi V, Rosenstein B, Roses D, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose–volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60:493–504
  100. Kozak KR, Smith BL, Adams J, Kornmehl E, Katz A, Gadd M, et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66:691–698
  101. Livi L, Paiar F, Banci Buonamici F, Scoccianti S, Meldolesi E, Scotti V, et al. Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. Tumori. 2005;91:227–232
  102. Leonard C, Carter D, Kercher J, Howell K, Henkenberns P, Tallhamer M, et al. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1291–1298
  103. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol. 1993;5:278–283
  104. Magee B, Swindell R, Harris M, Banerjee SS. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol. 1996;39:223–227
  105. Luini A, Orecchia R, Gatti G, Intra M, Ciocca M, Galimberti V, et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat. 2005;93:55–59
  106. Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg. 2005;242:101–106
  107. Intra M, Gatti G, Luini A, Galimberti V, Veronesi P, Zurrida S, et al. Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg. 2002;137:737–740
  108. Mussari S, la Sala WS, Busana L, Vanoni V, Eccher C, Zani B, et al. Full-dose intraoperative radiotherapy with electrons in breast cancer: first report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol. 2006;182:589–595
  109. Ollila DW, Klauber-Demore N, Tesche LJ, Kuzmiak CM, Pavic D, Goyal LK, et al. Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol. 2007;14:660–669
  110. Proulx GM, Hurd T, Lee RJ, Stomper PC, Podgorsak MB, Edge SB. Intraoperative radiation therapy (IORT) to the tumor bed only for breast cancer: technique and outcome. Radiol Oncol. 2001;35
  111. Vaidya JS, Baum M, Tobias JS, D’Souza DP, Naidu SV, Morgan S, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol. 2001;12:1075–1080
  112. Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer. 1990;26:671–673
  113. Sarin R. Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat Clin Pract Oncol. 2005;2:40–47
  114. McCormick B. Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. JNCCN. 2005;3:301–307
  115. Polgar C, Strnad V, Major T. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol. 2005;15:116–122
  116. Orecchia R, Ciocca M, Tosi G, Franzetti S, Luini A, Gatti G, et al. Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme. Breast. 2005;14:541–546

PII: S0167-8140(08)00434-9

doi: 10.1016/j.radonc.2008.08.005

Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 1-13 , January 2009

Article Tools